Andy Lundin, Author at Advanced Oncology

How Biomarker Discovery is Shaping the Future of Oncology Clinical Trials

New biomarker technologies are revolutionizing oncology clinical trials, enhancing diagnostic precision, and accelerating drug development.

The integration of AI into digital pathology is transforming cancer diagnostics by improving accuracy, efficiency, and treatment plans

Posted by Andy Lundin | May 23, 2024 | Liquid Biopsy |

Liquid biopsies are transforming oncology by providing real-time genetic insights into tumors, allowing for precise and dynamic treatment.

Posted by Andy Lundin | May 23, 2024 | Advanced Imaging |

The integration of PET and MRI into a single modality, PET/MRI, represents a significant advancement in oncology imaging.

Posted by Andy Lundin | May 23, 2024 | Advanced Imaging |

Positron Emission Tomography (PET) imaging has significantly evolved, providing critical advancements in the early detection of cancer.